PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem

Published: 25 October 2021

  • Views:

    Views Icon 8165
  • Likes:

    Heart Icon 7
  • episode_image
    3m 45s
    Part 2 | Session 9 Key Findings Nicolas M Van Mieghem
Average (ratings)
No ratings
Your rating

Overview

In this video series, Professor Nicolas van Mieghem will discuss the benefits of iVAC 2L ® in clinical practice and will share the learnings and key outcomes from the Pulse Trial, and the effect of next generation pulsatile mechanical circulatory support (MCS).

 

This video is supported by PulseCath in collaboration with their co-sponsors: CardiRad, Sanomed, LeviBio, Thomy F.E., Sonimed and Dot Medical.

 

Click Here for Publication: Effect of next generation pulsatile mechanical circulatory support on cardiac mechanics - The PULSE trial

 

This video series is sponsored by:

Key Learning Objectives

  • Learn when to use the short term percutaneous ventricular assist device (pVAD), iVAC 2L ® in clinical practice
  • Understand the differences between pulsatile and continuous flow
  • Understand the technology behind the device
  • Gain a better understanding of how the iVAC 2L ® is more efficient
  • Learn how to identify the right patient (HR PCI)
  • Learn when to use iVAC 2L ® vs Impella
  • Further understanding of large bore access management

Target Audience

  • Interventional Cardiologists
  • Cardiac Surgeons
  • Cardiac Nurses
  • Cath Lab Nurses
  • ICU Doctors
  • Perfusionists
  • Cath Lab Technicians

More from this programme

Part 1

Full Programme - PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem

Watch the entire webinar on the benefits of iVAC 2L ® in clinical practice brought to you by Prof Nicolas van Mieghem

Part 3

iVAC 2L ® - pVAD procedure

Watch the animation video of the iVAC 2L ® - pVAD procedure

Part 4

Pulsatile LV support during high-risk PCI

Dr Joost Daemen from Erasmus Medical Centre in the Netherlands talks through some of the basic concepts of pulsatile LV support during high-risk PCI

Part 5

iVAC 2L experience from CINRE hospital – Bratislava - Slovakia

Dr Ota Hilnomaz reviews his experience of the iVAC 2L

Part 6

iVAC 2L experience from University Hospital Centre Zagreb, Zagreb, HR

Prof Joško Bulum, University Hospital Centre Zagreb, Zagreb, HR shares his experience on the iVAC 2L and treating more complicated PCI patients.

Part 7

Procedure IVAC 2L in high risk PCI University Hospital of Bellvitge, Barcelona, (Spanish)

Dr Joan Antoni Gomez-Hospital (University Hospital of Bellvitge, Barcelona, ES) shares his experience on the iVAC 2L and the practical issues. 

Part 8

iVAC 2L experience from University Hospital of Bellvitge, Barcelona, ES

Faculty Biographies